- Report
- July 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- April 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- April 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- November 2024
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- February 2026
- 233 Pages
Canada
From €4502EUR$4,850USD£3,758GBP
- Report
- February 2026
- 242 Pages
China
From €4502EUR$4,850USD£3,758GBP
- Report
- February 2026
- 234 Pages
Germany
From €4502EUR$4,850USD£3,758GBP
- Report
- February 2026
- 235 Pages
India
From €4502EUR$4,850USD£3,758GBP
- Report
- March 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- June 2025
- 200 Pages
Global
From €2589EUR$2,789USD£2,161GBP
- Report
- October 2025
- 160 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- October 2025
- 160 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- August 2025
- 150 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- August 2025
- 150 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- August 2024
- 259 Pages
Global
From €3341EUR$3,600USD£2,790GBP
- Report
- August 2024
- 123 Pages
North America
From €1392EUR$1,500USD£1,162GBP
- Report
- August 2024
- 134 Pages
Middle East, Africa
From €1392EUR$1,500USD£1,162GBP
- Report
- August 2024
- 133 Pages
Europe
From €1392EUR$1,500USD£1,162GBP

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more